FDA Inspection
Octapharma Plasma IncOctapharma Plasma Inc – FDA Inspection, Apr 1, 2015
Record Details
This FDA Inspection record concerns Octapharma Plasma Inc, with an inspection on April 1, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma Inc
- Inspection Date
- April 1, 2015
- Product Type
- Biologics
View Company Profile
ID · 4c295182-1d9c-448b-a40a-04838402a6a8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 920586
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 600.10(b)Personnel capabilities
- 21 CFR 640.61Explanation of hazards
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 10, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 13, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma Inc
- FDA Inspection 1153080 - 2021-09-09
- FDA Inspection 1008992 - 2017-03-30
- FDA Inspection 780527 - 2012-05-10
- FDA Inspection 759822 - 2011-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.